You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 4, 2024

CLINICAL TRIALS PROFILE FOR LYSTEDA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LYSTEDA

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00113568 ↗	Safety Study of XP12B in Women With Menorrhagia	Completed	Ferring Pharmaceuticals	Phase 3	2005-06-01	The purpose of this study is to evaluate the safety of XP12B in women with heavy menstrual bleeding associated with menorrhagia.
NCT00386308 ↗	Efficacy and Safety Study of XP12B in Women With Menorrhagia	Completed	Ferring Pharmaceuticals	Phase 3	2006-10-01	The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
NCT00401193 ↗	Efficacy and Safety of XP12B in Women With Menorrhagia	Completed	Ferring Pharmaceuticals	Phase 3	2006-11-01	The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
NCT01190150 ↗	Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding	Completed	Ferring Pharmaceuticals	Phase 4	2010-08-01	This is a Phase 4, randomized, 2-way crossover, pharmacokinetic study of Lysteda (tranexamic acid) tablets administered as single doses of 0.65 g and 1.3 g in fasting adolescent female subjects ages 12-16 years with heavy menstrual bleeding.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LYSTEDA

Condition Name

Chart
Table

Condition Name for LYSTEDA
Intervention	Trials
Menorrhagia	6
Heavy Menstrual Bleeding	5
Blood Loss, Surgical	3
Hemorrhage	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LYSTEDA
Intervention	Trials
Hemorrhage	14
Menorrhagia	9
Blood Loss, Surgical	3
Thrombosis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LYSTEDA

Trials by Country

Map
Table

Trials by Country for LYSTEDA
Location	Trials
United States	159
Turkey	1
United Kingdom	1
Australia	1
Brazil	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LYSTEDA
Location	Trials
Missouri	7
California	7
Michigan	6
Georgia	6
Arizona	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LYSTEDA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LYSTEDA
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	7
Phase 2/Phase 3	1
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LYSTEDA
Clinical Trial Phase	Trials
Completed	14
Recruiting	6
Unknown status	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LYSTEDA

Sponsor Name

Chart
Table

Sponsor Name for LYSTEDA
Sponsor	Trials
Ferring Pharmaceuticals	5
American College of Obstetricians and Gynecologists	1
University of Pittsburgh	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LYSTEDA
Sponsor	Trials
Other	28
Industry	7
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.